116 related articles for article (PubMed ID: 2995065)
1. Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart.
Xiang JZ; Linz W; Becker H; Ganten D; Lang RE; Schölkens B; Unger T
Eur J Pharmacol; 1985 Jul; 113(2):215-23. PubMed ID: 2995065
[TBL] [Abstract][Full Text] [Related]
2. Local inhibition of angiotensin II formation and bradykinin degradation in isolated hearts.
Schölkens BA; Linz W
Clin Exp Hypertens A; 1988; 10(6):1259-70. PubMed ID: 2975971
[TBL] [Abstract][Full Text] [Related]
3. Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril.
Linz W; Schölkens BA; Kaiser J; Just M; Qi BY; Albus U; Petry P
Cardiovasc Drugs Ther; 1989 Dec; 3(6):873-82. PubMed ID: 2535056
[TBL] [Abstract][Full Text] [Related]
4. Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats.
Unger T; Ganten D; Lang RE; Schölkens BA
J Cardiovasc Pharmacol; 1984; 6(5):872-80. PubMed ID: 6209494
[TBL] [Abstract][Full Text] [Related]
5. Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts.
Linz W; Schölkens BA
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S75-82. PubMed ID: 2485067
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts.
Linz W; Schölkens BA; Han YF
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S91-9. PubMed ID: 2438498
[TBL] [Abstract][Full Text] [Related]
7. Effects of sympathetic nerve stimulation are attenuated by the converting enzyme inhibitor Hoe 498 in isolated rabbit hearts.
Xiang JZ; Schölkens BA; Ganten D; Unger T
Clin Exp Hypertens A; 1984; 6(10-11):1853-7. PubMed ID: 6099770
[No Abstract] [Full Text] [Related]
8. Blockade of angiotensin signaling improves myocardial function in hypercholesterolemia independent of changes in eicosanoid release.
Schwemmer M; Sommer O; Bassenge E
Cardiovasc Drugs Ther; 2000 Jun; 14(3):317-27. PubMed ID: 10935154
[TBL] [Abstract][Full Text] [Related]
9. Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist.
Schölkens BA; Linz W; König W
J Hypertens Suppl; 1988 Dec; 6(4):S25-8. PubMed ID: 2853732
[TBL] [Abstract][Full Text] [Related]
10. [Comparisons of effects of Hoe-498 and enalapril in isolated guinea pig hearts and rat myocardium].
Xiang JZ; Schölkens BA; Linz W; Unger T; Ganten D; Lang RE
Zhongguo Yao Li Xue Bao; 1985 Jun; 6(2):96-9. PubMed ID: 3002124
[No Abstract] [Full Text] [Related]
11. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
Moursi MG; Ganten D; Lang RE; Unger T
J Hypertens Suppl; 1986 Oct; 4(3):S495-8. PubMed ID: 3023591
[TBL] [Abstract][Full Text] [Related]
12. Converting enzyme inhibitors and brain angiotensin.
Phillips MI; Kimura B
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S82-90. PubMed ID: 2438497
[TBL] [Abstract][Full Text] [Related]
13. [Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)].
Unger T; Moursi MG; Lebrun C; Ganten D; Lang RE
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):971-4. PubMed ID: 3026275
[TBL] [Abstract][Full Text] [Related]
14. Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats.
Unger T; Ganten D; Lang RE; Schölkens BA
J Cardiovasc Pharmacol; 1985; 7(1):36-41. PubMed ID: 2580148
[TBL] [Abstract][Full Text] [Related]
15. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
16. Protection against L-NAME-induced reduction in cardiac output persists even after cessation of angiotensin-converting enzyme inhibitor treatment.
Biwer LA; Broderick TL; Xu H; Carroll C; Hale TM
Acta Physiol (Oxf); 2013 Jan; 207(1):156-65. PubMed ID: 22834875
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
Laubie M; Schiavi P; Vincent M; Schmitt H
J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
[TBL] [Abstract][Full Text] [Related]
18. Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: therapeutic implications.
Unger T; Ganten D; Lang RE
Am J Cardiol; 1987 Apr; 59(10):18D-22D. PubMed ID: 3034027
[TBL] [Abstract][Full Text] [Related]
19. Participation of prostaglandins and bradykinin in the effects of angiotensin II and converting enzyme-inhibition on sympathetic neurotransmission in vivo.
Schwieler JH; Kahan T; Nussberger J; Hjemdahl P
Acta Physiol Scand; 1994 Sep; 152(1):83-91. PubMed ID: 7810335
[TBL] [Abstract][Full Text] [Related]
20. The effect of endothelin on noradrenergic transmission in rat and guinea-pig atria.
Reid JJ; Wong-Dusting HK; Rand MJ
Eur J Pharmacol; 1989 Sep; 168(1):93-6. PubMed ID: 2555203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
